
CLS · NYSE
The supplied consensus is Buy from all seven analysts, with a mean price target of $475. The low and high targets are not reported, so target clustering and the width of the target spread cannot be established, and the evidence does not identify the most or least bullish analyst. Zacks says analysts are raising earnings estimates and describes strong agreement on that trend, but the supplied material does not document a named firm’s rating or target revision during the week. The substantive disagreement is between Celestica’s exposure to AI networking, hyperscaler spending and raised guidance, and concern that the stock already trades at a premium. No firm-specific target dispersion is available to quantify that debate.